APA (7th ed.) Citation

T, T., D, R., LM, F., M, O., K, M., & K, B. (2024). Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer. Cancer epidemiology, 88, 102516. https://doi.org/10.1016/j.canep.2023.102516

Chicago Style (17th ed.) Citation

T, Tiruye, Roder D, FitzGerald LM, O'Callaghan M, Moretti K, and Beckmann K. "Utility of Prescription-based Comorbidity Indices for Predicting Mortality Among Australian Men with Prostate Cancer." Cancer Epidemiology 88 (2024): 102516. https://doi.org/10.1016/j.canep.2023.102516.

MLA (9th ed.) Citation

T, Tiruye, et al. "Utility of Prescription-based Comorbidity Indices for Predicting Mortality Among Australian Men with Prostate Cancer." Cancer Epidemiology, vol. 88, 2024, p. 102516, https://doi.org/10.1016/j.canep.2023.102516.